Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents

The combination of venetoclax with hypomethylating agents (VEN-HMAs) showed promising activity in newly diagnosed and relapsed/refractory (r/r) acute myeloid leukemia (AML). Treatment with VEN-HMAs results in prolonged cytopenia, thereby exposing patients to invasive fungal infections (IFIs). Here,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Autores principales: Aldoss, Ibrahim, Dadwal, Sanjeet, Zhang, Jianying, Tegtmeier, Bernard, Mei, Matthew, Arslan, Shukaib, Al Malki, Monzr M., Salhotra, Amandeep, Ali, Haris, Aribi, Ahmed, Sandhu, Karamjeet, Khaled, Samer, Snyder, David, Nakamura, Ryotaro, Stein, Anthony S., Forman, Stephen J., Marcucci, Guido, Pullarkat, Vinod
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2019
Materias:
Myeloid Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6963254/
https://ncbi.nlm.nih.gov/pubmed/31816059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000930
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares